松井股份(688157.SH):發光保險槓項目已獲得吉利某車型定點與量產
格隆匯11月3日丨松井股份(688157.SH)接受特定對象調研時表示,近年來,公司一直採取“技術+市場”雙驅動策略,不斷加強新客户市場開拓,並取得良好成效,已與眾多知名終端及汽車零部件廠商建立合作。今年更多重心在於深入挖掘重點客户,拓寬合作邊界,共同打造項目行業標杆,以不斷提升產品的市場影響力與份額。
發光保險槓塗層解決方案開創了電動汽車家族化臉譜設計先河,是公司實施零部件塗層材料“由內到外”路徑突破的重要落腳點,該項目已獲得吉利某車型定點與量產,目前公司正在全力保障項目平穩交付和落地。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.